Search’n Build™

F. Schad  

Long-term Supportive Treatment with the Fermented Mistletoe (Viscum album L.) Extract from Pine Tree (Host Tree pinus) in Addition to Conventional Oncological Therapy in Primary Non-metastatic Breast Cancer
2009-10-11 - English


Camilla Böckelman  

CIP2A is a marker of reduced survival in serous ovarian cancer patients
2009-10-11 - English

CIP2A is a marker of reduced survival in serous ovarian cancer patients

Camilla Böckelman [1,2,3], Heini Lassus [4], Annabrita Hemmes [1,2], Jukka Westermarck [5,6], Arto Leminen [4], Caj Haglund [3], Ralf Bützow [2,4], Ari Ristimäki [1,2,7]

[1] Genome-Scale...(more)


Ruud L.M Bekkers  

Diagnostic accuracy of liquid-based compared with conventional cytology: results from the NETHCON cluster randomized controlled trial
2009-10-11 - English


Hariadi Yuseran  

The combination of clinicopathological factors, MMP-2, MMP-9 and VEGF as the lymph node metastasis predictor in early stage cervical cancer
2009-10-11 - English


Lucie Moukova  

The initial experience with detection of the gene amplification for human telomerase (hTERC) in precancers and carcinoma of the uterine cervix
2009-10-11 - English


Ilan Bruchim  

Targeting of the IGF-1R as a potential therapeutic strategy in endometrial cancer
2009-10-11 - English


Adam Rosenthal  

The UK Familial Ovarian Cancer Screen Study (UK FOCSS): Final Results of Annual Screening
2009-10-11 - English


Ranjit Manchanda  

Risk Reducing Salpingo-Oophorectomy in Women at Risk of Familial Ovarian Cancer Unselected for Mutation Status
2009-10-11 - English